We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$412M
AUM Growth
+$70.8M
Cap. Flow
+$36.5M
Cap. Flow %
8.87%
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234

Top Buys

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$1.67M
2
DCI icon
Donaldson
DCI
+$1.6M
3
FDX icon
FedEx
FDX
+$1.6M
4
FNF icon
Fidelity National Financial
FNF
+$1.53M
5
GGG icon
Graco
GGG
+$1.51M

Top Sells

Rank Stock Value
1
CDNS icon
Cadence Design Systems
CDNS
+$1.48M
2
TIC
TIC Solutions Inc
TIC
+$1.48M
3
SDGR icon
Schrodinger
SDGR
+$1.27M
4
EXC icon
Exelon
EXC
+$1.23M
5
VC icon
Visteon
VC
+$1.22M

Sector Composition

Rank Sector Weight
1 Industrials 18.1%
2 Financials 16.8%
3 Healthcare 15.07%
4 Technology 12.86%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACVA icon
251
ACV Auctions
ACVA
$1.19B
$602K 0.15%
83,685
+31,307
+60% +$177K
NABL icon
252
N-able
NABL
$767M
$601K 0.15%
+163,825
New +$681K
SHO icon
253
Sunstone Hotel Investors
SHO
$2.06B
$601K 0.15%
+52,500
New +$551K
MGY icon
254
Magnolia Oil & Gas
MGY
$6.35B
$601K 0.15%
23,498
CAI
255
Caris Life Sciences
CAI
$7.08B
$601K 0.15%
+33,719
New +$604K
KREF
256
KKR Real Estate Finance Trust
KREF
$492M
$598K 0.15%
87,496
+20,075
+30% +$133K
AMTB icon
257
Amerant Bancorp
AMTB
$1.16B
$596K 0.14%
23,364
MRVI icon
258
Maravai LifeSciences
MRVI
$1.09B
$594K 0.14%
95,186
+9,983
+12% +$43.1K
TKO icon
259
TKO Group
TKO
$13.6B
$592K 0.14%
+2,939
New +$573K
INTU icon
260
Intuit
INTU
$91B
$590K 0.14%
+2,261
New +$788K
SRCE icon
261
1st Source
SRCE
$2.1B
$589K 0.14%
7,214
STRA icon
262
Strategic Education
STRA
$1.81B
$587K 0.14%
7,662
-4,872
-39% -$385K
NTSK
263
Netskope Inc
NTSK
$5.7B
$587K 0.14%
+53,656
New +$546K
MOG.A icon
264
Moog Inc Class A
MOG.A
$11.8B
$586K 0.14%
1,383
-819
-37% -$280K
EFX icon
265
Equifax
EFX
$20.8B
$581K 0.14%
+3,662
New +$624K
AGO icon
266
Assured Guaranty
AGO
$3.33B
$581K 0.14%
7,247
+3,206
+79% +$253K
LFST icon
267
Lifestance Health
LFST
$4.86B
$581K 0.14%
54,236
-68,694
-56% -$531K
SN icon
268
SharkNinja
SN
$24.4B
$581K 0.14%
3,814
+1,634
+75% +$196K
SNN icon
269
Smith & Nephew
SNN
$12.1B
$579K 0.14%
20,109
+12,490
+164% +$388K
FLGT icon
270
Fulgent Genetics
FLGT
$543M
$575K 0.14%
27,999
+12,254
+78% +$208K
NWL icon
271
Newell Brands
NWL
$2.6B
$573K 0.14%
+93,258
New +$394K
NAT icon
272
Nordic American Tanker
NAT
$1.54B
$571K 0.14%
103,079
+35,287
+52% +$200K
MFG icon
273
Mizuho Financial
MFG
$136B
$571K 0.14%
59,559
+16,078
+37% +$144K
QCRH icon
274
QCR Holdings
QCRH
$1.68B
$569K 0.14%
5,845
NGVT icon
275
Ingevity
NGVT
$2.43B
$568K 0.14%
+7,603
New +$547K

Similar funds

EntryPoint Capital's Q2 2026 Portfolio in Review

As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.

  • EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
  • EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
  • EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
  • EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
  • EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
  • EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
  • EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.